[Use of erythropoietin in children with terminal renal insufficiency treated with chronic hemodialysis]. 1992

A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
University Children's Hospital, Belgrade, Yugoslavia.

Nine pts, aged 4-20 years (mean 12) with chronic uremic anaemia (mean Hb 5.8 g/dl, range 5.0-7.0 g/dl) on regular thrice-weekly haemodialysis, were treated with human recombinant erythropoietin (rh-uEPO) for a mean of 28.11 weeks (range 4-48). To attain a target Hb concentration (9.6-11.2 g/dl) RH-uEPO (Cilag) was administered i.v. after each dialysis in increasing doses within the range (51-300 U/kg/week). All pts were treated with persantine. Five pts needed iron supplementation. All pts showed increased Hb concentration and none of 6 previously transfusion dependent pts needed further transfusions after the first week of rH-uEPO. Pretreatment long-term dialyzed, polytransfused and iron overloaded pts, even when treated with lower doses of rH-EPO, responded better, reaching target Hb level from the 8th- to the 16th week. Three of 4 highly sensitized pts on rH-EPO treatment had a significant decrease of cytotoxic antibody titre, and 2 were successfully transplanted. rH-EPO also significantly improved the life quality in all pts. No pts developed any serious side affects. There was a transient increase in BP (2 pts) and transaminase with eosinophilia (4 pts).

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
January 1996, Revista medica de Panama,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
January 1981, Revue medicale de Liege,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
January 1990, Nephrologie,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
May 1980, Revue medicale de la Suisse romande,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
June 1989, Boletin medico del Hospital Infantil de Mexico,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
January 1990, Acta medica Iugoslavica,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
August 1979, Tijdschrift voor ziekenverpleging,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
January 1980, Problemy gematologii i perelivaniia krovi,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
January 1981, La Revue de medecine interne,
A Peco-Antić, and M Popović-Rolović, and O Jovanović, and M Kostić, and D Kruscić
September 1972, Minerva medica,
Copied contents to your clipboard!